Results of the FUEL Trial DJ Goldberg, V Zak, BH Goldstein, KR Schumacher, J Rhodes, DJ Penny, ... Circulation 141 (8), 641-651, 2020 | 125 | 2020 |
Impact of SLCO1B1 Genotype on Pediatric Simvastatin Acid Pharmacokinetics JB Wagner, S Abdel‐Rahman, L Van Haandel, A Gaedigk, R Gaedigk, ... The Journal of Clinical Pharmacology 58 (6), 823-833, 2018 | 39 | 2018 |
PharmVar GeneFocus: SLCO1B1 LB Ramsey, L Gong, S Lee, JB Wagner, X Zhou, K Sangkuhl, SM Adams, ... Clinical Pharmacology & Therapeutics 113 (4), 782-793, 2023 | 31 | 2023 |
Drug dose selection in pediatric obesity: available information for the most commonly prescribed drugs to children KE Kyler, J Wagner, C Hosey-Cojocari, K Watt, V Shakhnovich Pediatric Drugs 21 (5), 357-369, 2019 | 29 | 2019 |
Pediatric pharmacokinetics J Wagner, SM Abdel-Rahman Pediatrics in review 34 (6), 258-269, 2013 | 29 | 2013 |
Pediatric statin administration: navigating a frontier with limited data J Wagner, SM Abdel-Rahman The Journal of Pediatric Pharmacology and Therapeutics 21 (5), 380-403, 2016 | 21 | 2016 |
Impact of genetic variation on pravastatin systemic exposure in pediatric hypercholesterolemia JB Wagner, S Abdel‐Rahman, R Gaedigk, A Gaedigk, G Raghuveer, ... Clinical Pharmacology & Therapeutics 105 (6), 1501-1512, 2019 | 20 | 2019 |
Loss of consciousness in the young child J Villafane, JR Miller, J Glickstein, JN Johnson, J Wagner, CS Snyder, ... Pediatric cardiology 42, 234-254, 2021 | 18 | 2021 |
Considerations for implementing precision therapeutics for children MJ McLaughlin, J Wagner, V Shahknovich, B Carleton, JS Leeder Clinical and Translational Science 12 (2), 140-150, 2019 | 17 | 2019 |
Impact of SLCO1B1 Genetic Variation on Rosuvastatin Systemic Exposure in Pediatric Hypercholesterolemia JB Wagner, S Abdel‐Rahman, A Gaedigk, R Gaedigk, G Raghuveer, ... Clinical and Translational Science 13 (3), 628-637, 2020 | 14 | 2020 |
Efficacy of weight reduction on pediatric nonalcoholic fatty liver disease: opportunities to improve treatment outcomes through pharmacotherapy CS Friesen, C Hosey-Cojocari, SS Chan, IL Csanaky, JB Wagner, ... Frontiers in Endocrinology 12, 663351, 2021 | 13 | 2021 |
Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children J Wagner, JS Leeder Pediatric Clinics 59 (5), 1017-1037, 2012 | 13 | 2012 |
Developmental considerations for the use of naltrexone in children and adolescents SL Stancil, S Abdel-Rahman, J Wagner The Journal of Pediatric Pharmacology and Therapeutics 26 (7), 675-695, 2021 | 11 | 2021 |
The impact of cerebral embolization during infant cardiac surgery on neurodevelopmental outcomes at intermediate follow-up RJ Naik, JB Wagner, D Chowdhury, ML Barnes, DS Wagner, KC Burson, ... Perfusion 29 (5), 443-449, 2014 | 11 | 2014 |
Quantification of pravastatin acid, lactone and isomers in human plasma by UHPLC-MS/MS and its application to a pediatric pharmacokinetic study L van Haandel, KT Gibson, JS Leeder, JB Wagner Journal of Chromatography B 1012, 169-177, 2016 | 10 | 2016 |
A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents K Ogungbenro, JB Wagner, S Abdel-Rahman, JS Leeder, A Galetin European journal of clinical pharmacology 75, 1227-1235, 2019 | 9 | 2019 |
Oseltamivir-warfarin interaction in hypoplastic left heart syndrome: case report and review J Wagner, SM Abdel-Rahman Pediatrics 135 (5), e1333-e1336, 2015 | 9 | 2015 |
Children are not small adults: specific findings in statin exposure and response in a growing population JB Wagner Clinical pharmacology and therapeutics 106 (2), 278, 2019 | 8 | 2019 |
Asymptomatic left ventricular myxoma in a 12-year-old male M Chlebowski, J O'Brien, C Hertzenberg, J Wagner Texas Heart Institute Journal 43 (3), 267-269, 2016 | 8 | 2016 |
Functional consequences of pravastatin isomerization on OATP1B1-mediated transport JB Wagner, M Ruggiero, JS Leeder, B Hagenbuch Drug Metabolism and Disposition 48 (11), 1192-1198, 2020 | 5 | 2020 |